Northwestern Mutual Wealth Management
ZYNE

Northwestern Mutual Wealth Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$2 – 3640
2022
Q4 		$2 Sell
3
-250
-99% -$159 ﹤0.01% 3313
2022
Q3 		$0 Buy
253
+250
+8,333% +$284 ﹤0.01% 3487
2022
Q2 		$0 Hold
3
– – ﹤0.01% 3566
2022
Q1 		$0 Buy
+3
New +$7 ﹤0.01% 3504

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northwestern Mutual Wealth Management's ZYNE Position: Q1 2023 in Review

Northwestern Mutual Wealth Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2023, closing a stake of 3 shares — an estimated $2 sold.

Northwestern Mutual Wealth Management first reported a position in ZYNE in Q1 2022 and held it in 4 quarters. The position peaked at $2 in Q4 2022. 44 funds tracked by Wall St. Rank hold ZYNE as of Q1 2023.

  • Northwestern Mutual Wealth Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 3 Zynerba Pharmaceuticals, Inc shares in Q1 2023, an estimated $2.
  • Northwestern Mutual Wealth Management first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2022 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Zynerba Pharmaceuticals, Inc position peaked at $2 in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.